JFL Life Sciences Limited (NSE:JFLLIFE)
India
· Delayed Price · Currency is INR 11.00
-0.25 (-2.22%)
At close: Mar 9, 2026
JFL Life Sciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Operating Revenue | 744.78 | 820.42 | 465.48 | 428.3 | 335.9 | 327.7 | Upgrade
|
| Other Revenue | - | - | 4.72 | 13.8 | 7.2 | - | Upgrade
|
| Revenue | 744.78 | 820.42 | 470.19 | 442.1 | 343.1 | 327.7 | Upgrade
|
| Revenue Growth (YoY) | -1.19% | 74.49% | 6.35% | 28.85% | 4.70% | 8.61% | Upgrade
|
| Cost of Revenue | 583.82 | 663.35 | 401.03 | 349.4 | 258.8 | 288.9 | Upgrade
|
| Gross Profit | 160.97 | 157.07 | 69.17 | 92.7 | 84.3 | 38.8 | Upgrade
|
| Selling, General & Admin | 7.96 | 12.62 | 9.16 | 18.6 | 15.6 | 9.6 | Upgrade
|
| Other Operating Expenses | 77.16 | 62.46 | 9.48 | 21.4 | 9.3 | 7.4 | Upgrade
|
| Operating Expenses | 95.59 | 85.01 | 23.06 | 44 | 27.3 | 19.6 | Upgrade
|
| Operating Income | 65.38 | 72.07 | 46.11 | 48.7 | 57 | 19.2 | Upgrade
|
| Interest Expense | -11.45 | -9.93 | -7.43 | -13.2 | -20.5 | -12.3 | Upgrade
|
| Interest & Investment Income | 0.08 | 0.08 | 0.26 | - | 1 | 0.8 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.4 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.05 | -0.86 | -1.01 | 1.7 | - | - | Upgrade
|
| Pretax Income | 52.95 | 61.35 | 37.93 | 37.2 | 37.9 | 7.8 | Upgrade
|
| Income Tax Expense | 17.79 | 19.77 | 4.92 | 9.1 | 9.9 | 2.2 | Upgrade
|
| Net Income | 35.17 | 41.59 | 33 | 28.1 | 28 | 5.6 | Upgrade
|
| Net Income to Common | 35.17 | 41.59 | 33 | 28.1 | 28 | 5.6 | Upgrade
|
| Net Income Growth | -34.40% | 26.00% | 17.45% | 0.36% | 400.00% | 55.38% | Upgrade
|
| Shares Outstanding (Basic) | 44 | 33 | 33 | 29 | 20 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 33 | 33 | 29 | 20 | 18 | Upgrade
|
| Shares Change (YoY) | 33.13% | - | 13.37% | 42.40% | 11.93% | 10.70% | Upgrade
|
| EPS (Basic) | 0.80 | 1.26 | 1.00 | 0.97 | 1.37 | 0.31 | Upgrade
|
| EPS (Diluted) | 0.80 | 1.26 | 1.00 | 0.97 | 1.37 | 0.31 | Upgrade
|
| EPS Growth | -50.74% | 26.00% | 3.57% | -29.52% | 346.69% | 40.37% | Upgrade
|
| Free Cash Flow | 26.81 | -39.27 | 22.95 | -90.5 | 6.3 | -63.3 | Upgrade
|
| Free Cash Flow Per Share | 0.61 | -1.19 | 0.70 | -3.11 | 0.31 | -3.47 | Upgrade
|
| Dividend Per Share | - | - | 0.083 | - | - | - | Upgrade
|
| Gross Margin | 21.61% | 19.14% | 14.71% | 20.97% | 24.57% | 11.84% | Upgrade
|
| Operating Margin | 8.78% | 8.78% | 9.81% | 11.02% | 16.61% | 5.86% | Upgrade
|
| Profit Margin | 4.72% | 5.07% | 7.02% | 6.36% | 8.16% | 1.71% | Upgrade
|
| Free Cash Flow Margin | 3.60% | -4.79% | 4.88% | -20.47% | 1.84% | -19.32% | Upgrade
|
| EBITDA | 75.5 | 81.65 | 50.19 | 53 | 60.7 | 21.8 | Upgrade
|
| EBITDA Margin | 10.14% | 9.95% | 10.67% | 11.99% | 17.69% | 6.65% | Upgrade
|
| D&A For EBITDA | 10.12 | 9.58 | 4.08 | 4.3 | 3.7 | 2.6 | Upgrade
|
| EBIT | 65.38 | 72.07 | 46.11 | 48.7 | 57 | 19.2 | Upgrade
|
| EBIT Margin | 8.78% | 8.78% | 9.81% | 11.02% | 16.61% | 5.86% | Upgrade
|
| Effective Tax Rate | 33.59% | 32.22% | 12.98% | 24.46% | 26.12% | 28.21% | Upgrade
|
| Revenue as Reported | 744.99 | 820.52 | 470.61 | 444.7 | 344.8 | 328.6 | Upgrade
|
| Advertising Expenses | - | 2.51 | 0.01 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.